Le Lézard
Classified in: Business
Subject: FNC

Deerpath Capital Closes Ninth Collateralized Loan Obligation


NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Deerpath Capital Management, LP announced the closing of Deerpath CLO 2023-2, a $353.65 million collateralized loan obligation (CLO). This marks Deerpath's second new issuance CLO in 2023. Including a CLO reset and upsize in July, this transaction represents the firm's ninth CLO over the past six years. Deerpath Capital is one of the largest providers of customized, cash-flow based senior debt financing to lower-middle market companies across North America.

Deerpath CLO 2023-2 brings the firm's total CLO assets under management to approximately $2.8 billion. Deerpath CLO 2023-2 is secured by a large and diversified portfolio of senior secured loans to middle market, private equity-backed companies. The loans in the portfolio have been primarily directly originated by the firm. 

Deerpath sold securities rated from AAA through BBB- to third-party institutional investors, including insurance companies, pension funds, banks, and asset managers. As with its other CLOs, Deerpath's managed funds purchased 100 percent of the subordinated notes issued by the CLO. Deerpath CLO 2023-2 has a four-year reinvestment period.

Derek Dubois, Managing Director and Treasurer said, "Deerpath has continued to programmatically access the debt capital markets at attractive terms for our investors. This is a testament to the strength of our platform as the leading direct lender focused on the lower middle market." 

GreensLedge Capital Markets LLC served as Lead Placement Agent and Structuring Agent. NatWest Markets served as Co-Placement Agent.

About Deerpath Capital Management, LP

Founded in 2007, Deerpath Capital Management, LP is one of the largest providers of customized, cash-flow based senior debt financing to lower-middle market companies across diverse industries. The firm currently manages approximately $7 billion of assets under management. For more information, please visit www.deerpathcapital.com.

Media:

Aidan O'Connor
Prosek Partners (On behalf of Deerpath Capital)
(646) 818-9283
[email protected]

SOURCE Deerpath Capital Management, LP


These press releases may also interest you

at 22:00
SAP SE today announced NEC Corporation (TSE: 6701 "NEC") has selected SAP S/4HANA Cloud through the RISE with SAP solution, running on Amazon Web Services (AWS). Together with implementation partner ABeam Consulting, the migration will leverage...

at 21:35
Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market....

at 21:05
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  ...

at 21:01
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 21:00
ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide. After more than 22 years of successful...

at 20:55
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...



News published on and distributed by: